Oral potentially malignant disorders: Is malignant transformation predictable and preventable?

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 19, Issue 4, 2014, Pages

  Van der Waal, Isaäc ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Oral leukoplakia; Oral lichen planus; Oral potentially malignant disorders

Indexed keywords

ARTICLE; EPITHELIUM DYSPLASIA; ERYTHROPLASIA; FOLLOW UP; GENE MUTATION; HUMAN; LEUKOPLAKIA; LICHEN PLANUS; MOUTH CANCER; PREDICTION; PREVALENCE; SMOKING CESSATION; CELL TRANSFORMATION; MOUTH NEOPLASMS; PATHOLOGY; PREDICTIVE VALUE;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LEUKOPLAKIA, ORAL; LICHEN PLANUS, ORAL; MOUTH NEOPLASMS; PREDICTIVE VALUE OF TESTS;

EID: 84903958560     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.20205     Document Type: Article

References (31)

1. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978;46:518-539.
2. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classifcation of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575-580.
3. Reichart PA, Philipsen HP. Oral erythroplakia. A review. Oral Oncol. 2005;41:551-561.
4. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42:461-474.
5. Zhang L, Williams M, Poh CF, Laronde D, Epstein JB. Toluidine blue staining identifes high-risk primary oral premalignant lesion with poor outcome. Cancer Res. 2005;65:8017-8021.
6. Nasser W, Flechtenmacher Chr, Holzinger D, Hofele Chr, Bosch FX. Aberrant expression of p53, p16INK4a and Ki-67 as basic bio-marker for malignant progression of oral leukoplakias. J Oral Pathol Med. 2011;40:629-635.
7. Siebers TJH, Bergshoeff VE, Otte-Höller I, Kremer B, Speel EJM, van der Laak JAWM, et al. Oral Oncology. 2013;49:1121-1128.
8. Graveland AP, Bremmer JF, de Maaker M, Brink A, Cobussen P, Zwart M, et al. Molecular screening of oral precancer. Oral Oncol. 2013;49:1129-1135.
9. Brouns EREA, Baart JA, Karagozoglu KH, Aartman IHA, Bloe-mena E, van der Waal I. Treat-ment results of CO2 laser vaporisation in a cohort of 35 patients with oral leukoplakia. Oral Dis. 2013;19:212-216.
10. Kuribayashi Y, Tsushima F, Sato M, Morita K, Omura K. Recurrence patterns of oral leu-koplakia after curtaive surgical resection: important factors that predict the risk of recurrence and malignancy. J Oral Pathol. 2012;41:682-688.
11. Arnaoutakis D, Bishop J, Westra W, Califano JA. Recurrence patterns and management of oral cavity premalignant lesions. Oral Oncol. 2013;49:814-817.
12. Arduino PG, Surace A, Carbone M, Elia A, Massolini G, Gan-dolfo S, et al, Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up. J Oral Pathol Med. 2009;38:540-544.
13. Brouns EREA, Baart JA, Karagozoglu KH, Aartman IHA, Bloe-mena E, van der Waal I. Malig-nant transformation of oral leukoplakia in a well defned cohort of 144 patients. Oral Dis. 2014;20:e19-e24.
14. Einhorn J, Wersall J. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer. 1967;20:2189-2193.
15. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev. 2006:CD001829.
16. Ribeiro AS, Salles PR, da Silva TA, Mesquita RA. A re view of the nonsurgical treatment of oral leukoplakia. Int J Dent. 2010;2010:186018.
17. Vladimirov BS, Schiödt M. The effect of quitting smoking on the risk of unfavorable events after surgical treatment of oral potentially malignant lesions. Int J Oral Maxillofac Surg. 2009;38:1188-1193.
18. Krutchkoff DJ, Cutler L, Laskowski S. Oral lichen planus: the evidence regarding potential ma-lignant transformation. J Oral Pathol. 1978;7:1-7
19. Voûte ABE, de Jong WFB, Schulten EAJM, Snow GB, van der Waal I. The possible premalig-nant character of oral lichen planus; the Amsterdam experience. J Oral Pathol Med. 1992;21:326-329.
20. Eisenberg E. Clinical controversies in oral and maxillofacial surgery. Part one. Oral lichen planus: a benign lesion. J Oral Maxillofac Surg. 2000;58:1278-1285.
21. Van der Meij EH, Mast H, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol. 2007;43:742-748.
22. Accurso BT, Warner BM, Knobloch ThJ, Weghorst CM, Shum-way BS, Allan CM, et al. Allelic imbalance in oral lichen planus ans assessment of its classifcation as a premalignant condition. Oral Surg Oral med Oral Pathol Oral Radiol Endod 2011;112:359-366.
23. Poomsawat S, Buajeeb W, Khovidhunkit SO, Punyasingh J. Overexpression of cdk4 and p16 in oral lichen planus supports the concept of premalignancy. J Oral Pathol Med. 2011;40:294-299.
24. Bombeccari GP, Guzzi G, Tettamanti M, Gianni AD, Baj A, Pal-lotti F, et al. Oral lichen planus and malignant transformation: a longitudinal cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:328-334.
25. Rad M, Hashemipoor MA, Mojtahedi A, Zarei MZ, Chamani G, Kakoei S, et al. Correlation between clinical and histopathologic diagnoses of oral lichen planus based on modifed WHO diagnostic criteria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:796-800.
26. Krutchkoff DJ, Eisenberg E. Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol. 1985;60:308-315.
27. Mattila R, Alanen K, Syrjänen S. Desmocollin expression in oral atrophic lichen planus corre-lates with clinical behavior and DNA content. J Cutan Pathol. 2008;35:832-838.
28. Chen Y, Zhang W, Geng N, Tian K, Jack Windsor L. MMPs, TIMP-2, and TGF-beta 1 in the cancerization of oral lichen planus. Head Neck. 2008;30:1237-1245.
29. Gonzales-Moles MA, Scully C, Ruiz-Avila L. Molecular findings in oral premalignant fields; update on their diagnostic and clinical implications. Oral Dis. 2012;18:40-47
30. Mattsson U, Jontell M, Holmstrup P. Oral lichen planus and malignant transformation: Is a recall of patients justified?. Crit Rev Oral Biol Med. 2002;13:390-396.
31. Mignona MD, Fedele S, Lo Russio L. Dysplasia/neoplasia surveillance in oral lichen planus patients: a description of clinical criteria adopted at a single centre and their impact on prognosis. Oral Oncol. 2006;42:819-824.